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Abstract
Every year the US and European countries face an epidemic of organ failure from a multitude of reasons: cancer, genetic
predisposition, exposure to harmful chemicals in home or surrounding areas or through drinking, drugs and smoking. Another
problem faced, is the ratio of organ donors to organ recipients. Over 121,000 patients are on the waiting for an organ transplant, and a
fraction of those waiting will die because of time. The Hanover Medical school and department of quality management, have created
an integrated approach to organ transplant avenues. Quality management is a systematic guide for organ transplantation that allows
all clinical trials to follow a standard operating procedure and protocol. This paper will talk about the use of integrated pathways in
transplantation management in US/EU transplant centers. It will also discuss how quality management plays an intricate/necessary
role in ensuring all clinical trials are efficient in organ transplantation and can meet the necessary demands of saving lives, while
improving outcomes of transplanting vital organs. I will also discuss the gaps present in clinical research and the current research
that’s being down to enhance the field of organ transplantation. The role of quality management is to ensure that all studies are
performed with proper efficacy, high ethical standards, and contain a set of clear standard operating procedures and protocols for
each clinical trial.
Key words: Clinical management, QMS, organ transplant
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Problems with Clinical Research
This summer I participating in a clinical research program through the University of Hochschule Hanover of Applied Science
and art in Germany. To complete my 300/hr. internship, I interned through the department of Quality management at the Hanover
Medical school. The U.S public health problems that are prevalent are: Accurate assessments of alloimmunity, simultaneous
dissemination of assays to the transplant community, which means making the screening process more thorough for detection of
disease, international exchange of data to optimize safety and efficacy leading to increased success within the clinical pathways of
organ transplantation, and uncovering the unmet needs of patient’s pre-transplantation, peri-transplantation & post transplantation.
Through the internship, I focused on the use of Clinical Pathways in organ transplantation management in the U.S./EU.
Every day on average, 22 people die while waiting for an organ transplant in the U.S and European countries. (UNOS, 2016).

The project I worked on was to see what clinical pathways are established for organ transplant management in the US/EU
transplant centers. The purpose was to find connections in how countries acquire/transport internal organs to organ recipients
around the world, and how the quality management can improve utilizing quality assurance and quality control within the clinical
setting. The public health problem is organ transplantation and the continuous gap that’s increasing between organ supply and
demand in the U.S and European countries (EU). In 2014, there were 39,973 organ transplants performed in the U.S with a 5%
increase from 2014 to 2015 (HRSA, 2015). There was a total of approximately 114,690 organ transplants worldwide, of which 30.9%
per 1000 transplants occurred in the U.S. and 25% in the European Union (EU) (HRSA, 2016). The World Health Organization (WHO)
has issued a resolution and guiding principles in consideration thereof, particularly noting the following challenges: The shortage of
available organs has not only prompted many countries to develop procedures and systems to increase supply but has also
stimulated commercial traffic in human organs, particularly from living donors who are unrelated to recipients. The evidence of such
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commerce, along with the related traffic in human beings, has become clearer in recent decades. Moreover, the growing ease of
international communication and travel has led many patients to travel abroad to medical centers that advertise their ability to
perform transplants and to supply donor organs for a single, inclusive charge (WHO, 2010). Second, there is a current awareness of
the growing magnitude and utility of human cell, tissue and organ transplantation for a wide range of conditions in low-resource as
well as high-resource countries; A third challenge is to ensure the safety, efficacy and ethical standards are followed for each patient
and future donor. The fourth challenge was stated in the resolutions WHA40.13 and WHA42.5 and first expressed the Health
Assembly’s concern over commercial trade in organs and the need for global standards for transplantation. Lastly, among the most
pressing challenges for population health researchers and clinicians is the accurate assessment of alloimmunity and simultaneous
dissemination of assays to the transplant community are essential for post-transplantation surveillance and international exchange of
data to optimize safety and efficacy (WHO,2010).

In response to this, a number of initiatives have been proposed, including the potential establishment of a global virtual
laboratory, the assessment of outcomes post-transplantation, and navigation of ethical and legal considerations. Developing a GVL
would mean disseminating detailed and rigorous protocols for the monitoring of alloimmune responses. It aims to initiate steps at
making standardized testing methods and expertise more accessible to the global transplant research community conducting clinical
trials (Geissler, Tullius, Chong, 2015). This will be able to implement novel transplantation strategies that can improve long-term
outcomes (one of our current most challenging issues).

4

Cassie Rodriguez
An integrative approach to organ transplantation

A quality management system (QMS) is a formalized system that documents processes, procedures, and responsibilities for
achieving quality policies and objectives. A QMS helps coordinate and direct clinical trial activities to meet patients and regulatory
requirements of that hospital and improve its effectiveness and efficiency on a continuous basis. The department of quality
management in Hanover Germany, created an avenue for an integrative approach to organ transplantation and how it can increase
success in organ treatment. Their purpose is reducing loss of organs, increase long-term success/results and increase the amount of
time an organ be en route to a patient in need (ASQ, 2015). The diagram below shows an integrative approach to organ transplant
avenues for organ transplantation, as well as, how other areas can contribute to the success of 1 of 5 main branches.
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Quality management allows continuous improvement in quality control, as well as, quality assurance of all clinical trials performed in
Germany. Germany has begun creating an integrative approach using quality management control within organ transplantation
systems. The QMS helps provide a systematic guide in the development of a robust system for reporting, investigating and resolving
all errors, accidents, adverse events and biological product deviations and complaints. This will ensure the “process” that is at fault or
having errors be fixed because it will be one of the most important aspects of safety in transplantation. Clinical research will have
more opportunities in achieving optimal success with having quality management oversight in all avenues (ASQ,2015).

One of the benefits of developing and implementing a QMP includes developing proactive communication among clinical trial
team members. This benefits clinical trial teams by encouraging early identification and resolution of clinical trial problems and
concerns. Implementing a Clinical Trial QMP can also encourage conformity with Standard Operating Procedure, Good Clinical
Practice (GCP), Good Laboratory Practice, and UCSF policies and procedures. This leads to an overall reduction in external
(Sponsor, FDA) and internal (UCSF) data queries, and helps reduce clinical trial closeout time (UCSF, 2015). All transplant related
procedures are subject to continuous review and improvement. If certain parts of the services provided by the transplant center are to
be amended significantly or a new field of procedure are developed, a new plan of development should be compiled and released by
the medical program director. This is the purpose of why quality management is a part of clinical research trials; it will provide access
to more reliable data/statistics, ensure ethical protocols are followed, monitor and measure the process and service
Another important aspect while working on integrative pathways in organ transplantation, is the transportation and allocation
for each organ. The purpose of this project was to find ways to increase the preservation time of each organ by creating new
techniques to store/transfer. Organ preservation remains an important contributing factor to graft and patient outcomes (Latchana,
Peck, Whitson, Henry, 2015). Today’s Current Standard of Care: The Picnic Cooler vs. OTS’ Revolutionary Technology: The
LifeCradle® Heart Perfusion System (OTS, 2012). Both techniques are in use and under review of which one will be able to preserve
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the organ the longest, which will give more flexibility with allocation of the organ. Focusing on preservation solutions represents one
potential avenue to improve patient and graft outcomes in transplantation and may be an effective strategy to decrease healthcare costs
associated with transplantation (Latchana, Peck, Whitson, Henry, 2015).
Shown below is a table that provides an example of treatment avenues and what qualifies a patient to receive an organ
transplant (i.e. diagnosis), and how to measure outcomes/patient survival. Measuring outcomes is extremely essential to measuring
success of treatment post-transplantation. Organ failure typically begins one-year post-operation, which is why quality management
control is an important avenue in organ transplant research.
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Organs

Dx receiving transplant

Tolerance: measuring
outcomes

In/out PT survival

Heart

CHD, CAD, HF, PHV, HD

Pre, peri, post trasnplant
protocols

Specific for each site
of transplant

Lung

Bilateral Lung Transplant; Cystic
fibrosis, Bronchiectasis,
Pulmonary
hypertension,Emphysema
Pulmonary fibrosis (idoiopathic
or secondary to scleroderma or
other disease states)

Quality of life and cost
effectiveness

FUNCTIONAL
OUTCOMES

When compared to liver and
kidney transplants, the longterm outcomes of LT are
worse.

-Overall quality of
life during post-Tx

Single Lung Transplant:
Emphysema, Pulmonary fibrosis
(idoiopathic or secondary to
scleroderma or other disease
states

Influence of pre-operative
diagnosis

% of
transplants
done
2804

U.S or
EU

2057

US

U.S

Influence of the type of
surgical procedure
Survival benefit

Kidney/Liver

DGF-Acute kidney injury

Survival outcomes will vary
based on disease type, age,
surgical procedures, etc

Pilot check lists for
management of ALF

17,878/7127

US

Pancreas

What is pancreatic islet
transplantation
Pancreas transplants are most
often done when a patient also
receives a new kidney.

MANAGEMENT

PANCREAS
TRANSPLANT
OUTCOMES posttransplant
-Rejection status
-Adverse effects
Diseases aquired
after transplants.

228

US

Immunosuppressants
Immunobiology, diagnosis,
and treatment of rejection
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Stem Cells

Multiple diagnosis

Depends on what procedure
was done.

Different patient
protocols are
designed per study.

N/A for this
study

Quality Management in a clinical research setting
The agency that I worked through was the department of quality management, which oversaw all clinical research trials in the
Hanover medical school. My directors team contained ~ 5 people, and the second team had ~20 people working on different projects
for the Hanover Medical School in biostatistics. The population they focus on are young pediatric and adult patients that are extremely
ill and require an organ transplant immediately. The purpose of having a quality management protocol in place, is to make sure all
clinical trials are being done properly and within the standard operating procedures. The overarching health problem that quality
management systems deal with are making sure all clinical trials are done within the scope of good clinical practice (GCP), SOP’s and
within the protocol. Short-term goals are to ensure a safe start to the trial and the risks to the patient are low and not harmful. Longterm goals for a clinical research trial are to approve the end result as a way to improve/save a life.
The objectives of my internship were as follows: to create an academic literature review and research Quality Management
and the type of clinical pathways use in organ transplantation. I was apart of several training sessions on quality management, organ
transplantation; writing SOP’s, and learning how to write/give an internal audit in a clinical research trial going on at the University
Hanover medical school. One study I was working on was a new initiative in sharing data with other clinical researchers in the field of
organ transplantation. I was asked to provide feedback on the subject and how the US would feel about this particular plan.

9

Cassie Rodriguez
Evaluation of Data Sharing Initiative (ICMJE)
Germany, is currently in the works of creating a system where all clinical trials will be required to responsibly share data
generated by interventional clinical trials because participants have put themselves at risk. In a growing consensus, many funders
around the world- foundations, government agencies, and industry, now mandate data sharing (New England Journal of Medicine,
2016). As a condition of consideration for publications of a clinical trial report in the member journals, the ICMJE proposes to require
authors to share with others the de-identified individual-patient data (IPD) underlying results presented in the article (including tables,
figures, and appendices or supplementary material, no later than 6 months after publication (New England Journal of Medicine, 2016).
Authorizing reliable data sharing is a major endeavor that will shape the fabric o how clinical trials are developed and conducted, and
how that data will be interpreted (New England Journal of Medicine, 2016). This requirement will revolutionize clinical studies, which
will save time, money and patients from redoing projects that have already be attempted of done successfully. It also aims, in part, to
prevent selective publication and selective reporting of research outcomes and to prevent unnecessary duplication of research effort
(New England Journal of Medicine, 2016). Data sharing will increase confidence and trust in conclusions drawn from clinical trails.
Initiating a Global Virtual Lab
Another stride being made in clinical research is the design of a global virtual lab within the United States. Currently, the US
is working on a Global virtual lab for transplantation as a means of developing and disseminating detailed and rigorous protocols for
monitoring of alloimmune responses. Global virtual labs are aimed at making standardized testing methods and expertise more
accessible to the global transplant research community conducting the clinical trials. This new tool will determine the (+/- ) effects that
have been undetected with biopsies or standard measurements of donor-specific antibodies. This new tool will allow for
communicating on a global scale with researchers/clinicians around the world. Serveral pros/cons and ethical legalities need to be
worked out for this to be a functional option. Also, the assessment of outcomes after transplantation is important for several reasons: it
provides patients with data so that they can make informed decisions about the benefits of transplantation and the success of the
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transplant unit; it informs commissioners that resources are allocated properly; and it provides clinicians reassurance that results are
acceptable or, if they are not, provides early warning so that problems can be identified, corrections can be instituted early, and all
interested parties can be reassured that scarce resources are used fairly.
›

RISK ADJUSTMENT

›

METHODS FOR COMPARING PERFORMANCE

›

WITHIN-CENTER MONITORING TECHNIQUES

›

BETWEEN-CENTER MONITORING TECHNIQUES

›

Cross-Validation Methods

›

Success will have a multitude of reasons and certain organs like the liver, kidney and lungs, will have data showing
higher trends compared to the heart or pancreas.

Pilot Checklist for Acute Liver Failure: ICU
In Germany, hospitals are taking a new route in providing excellent patient care before, during and post surgery. An acute liver
failure checklist was created for the ICU to develop a management strategy to ensure patient safety and efficacy of staff
management. The checklist can be utilized among multiple provides in different areas. The Initial checklist was developed from
published guidelines and expert opinion. A total of 81 surveys involving management of 116 patients were done during a pilot
testing period. The checklist underwent pilot testing at 11 academic liver transplant centers in US and Canada. An anonymous,
written survey was given to assess overall usability and feasibility of the checklist.
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Results/Findings
Although, there is extensive knowledge in the field of organ transplantation, there are still too many gaps that need to be
filled. These include death post-transplantation, incidences of infection/diseases and a decrease in long-term survival rates. Shown
below is an example of the the country leading the way in organ donation on a global health scale. Spain ranks number one, yet for the
US they’re ranked 6th. Spain has the highest organ donation rate due to outstanding donor detection and organ procurement and all
other countries are lagging significantly behind. Spain has accomplished something the US will aspire to accomplish in the next 5
years.

Although strides have been made, there are still several gaps present. For the people to find information on clinical pathways
hospitals use as guidelines, it was nearly impossible to find. Also, there are still too many challenges face in organ transplantation i.e.
heart transplantation post-transplant. The discouragement being there is has been no changes in decades and the current shortage of
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organs is also an issue. The other gap in the field is the lack of patient education for potential problems post-transplantation. Germany
is currently trying to fix this problem with a quality management system guide in organ transplantation. This QMS guide allows
doctors to have a set of standards to follow, but after each section in the guide there is a survey of how each doctor viewed its
feasibility. Shown below is another advancement made in the field of the total maximum time an organ can be transplanted on ice or
machine. This graph is also being update as we speak.
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Conclusion and Future Steps
As interest in value-based healthcare continues to drive use of pathways, we need to better understand how they impact patient
experience, outcomes and expenditures. Organ transplantation is a growing field and heading in the right direction. Currently, there are
over 300 clinical trials going on in Germany, and quality management systems have a huge role in making sure they are done with
precision, efficacy and provide the adequate safety to all patients participating. The field of organ transplantation requires more than ever,
more research on uncovering new strategies in dealing with the growing disparity of organs, as well as, decreasing the risk factors posttransplantation. Programs will benefit by incorporating focus group interviews for the doctors and patients, and conducting a quantitative
data analysis on the primary data. All clinical research trials play an important role in providing life to patients in need. Ten years from
now the goal is to create organs that can be self-sufficient, and not having to rely on organ donation. For the purpose of QM in organ
transplantation, through observation: A “one size fits all” approach to transition won’t work. We must work with each individual patient’s
unique physical, cognitive and psychosocial abilities. We need to continue collecting & examining global data on the practices, safety,
efficacy, quality & epidemiology of allogeneic transplantation, and on ethical issues including living donation, in order to update the WHO
Guiding Principles on Human Organ Transplantation (WHO, 2010). The use of international relations is still non-existent within clinical
research. Until these relations are better established the field of organ transplantation will not excel.
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Application of MPH coursework
Final Learning Objectives
Goal 1:
Objectives (S)

Quality management &
clinical pathways use in
organ transplantation
centers in U.S and EU.
Goal 2:
Objectives (S)

Activities

Literature & research, (), May 26, 2016
compilation of summary
reports and presentation.

Activities

Standard operating
Attended training
procedures, formatting and sessions
(..)
Goal 3:
Objectives (S)

Start/End Date

C. Rodrigues & M.
Barthold

Start/End Date

June 23, 2016

Activities

Activities

Start/End Date

Evaluation of data sharing Literature review
May
Initiative ICMJE
sharing Initiative ICMJE
presentation of pros/cons *
with team.
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Who is Responsible

C. Rodrigues & M.
Barthold

Start/End Date

26th-June

Who is Responsible

Tracking Measures

Checking in every few
hours and going over each
step to ensure I was on
the right track.
Tracking Measures

C. Rodrigues & M.
Barthold

Working on an Audit for a Working on a moc audit June 27, 2016
current clinical trial in
to understand the format
progress
techniques and what
goes into an audit
Goal 4:
Objectives (S)

Who is Responsible

26th.

Who is Responsible

C. Rodrigues & M.
Barthold

Tracking Measures

Moc interview

Tracking Measures

Presentation review
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Master of Public Health Program
MPH PROGRAM COMPETENCY INVENTORY
USF MPH Competencies
1. Assess, monitor, and review the
health status of populations and
their related determinants of health
and illness.
2. Demonstrate the ability to utilize
the proper statistical and
epidemiologic tools to assess
community needs and program
outcomes.
3. Identify and prioritize the key
dimensions of a public health
problem by critically assessing
public health literature utilizing both
quantitative and qualitative
sources.
4. Specify approaches for assessing,
preventing, and controlling
environmental hazards that pose
risks to human health and safety.
5. Apply theoretical constructs of
social change, health behavior and
social justice in planning
community interventions.
6. Articulate the relationship between
health care delivery and financing,
public health systems, and public
policy.
7. Apply evidence-based principles to
the process of program planning,
development, budgeting,
management, and evaluation in
public health organizations and
initiatives.
8. Demonstrate leadership abilities as
collaborators and coordinators of
evidence based public health
projects.
9. Identify and apply ethical, moral,
and legal principles in all aspects of
public health practice.
10. Develop public health programs
and strategies responsive to the
diverse cultural values and
traditions of the communities being
served.

Proposed Activities
Internalized data sets of organ
transplant donors/recipients

Number of
Hours
(Estimated)

5/hr

N/A

Created an academic synopsis
utilizing 15-20 peer-reviewed
literature on clinical pathways in
organ transplantation

10 hours

N/A

Helped analyze data sets to show
the trends of social change

~2-3/hr

N/A

I learned how the department of
2/hrs
QM does their program planning,
and evaluations within clinical trials.
I collaborated with the director to 5/hr
help uncover new evidence-based
practices in quality management
Uncovered new routes to increasing 2/hr
moral standards with my director
N/A
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11. Effectively communicate public
health messages to a variety of
audiences from professionals to
the general public.
12. Advance the mission and core
values of the University of San
Francisco.

CEPH Core Knowledge Areas

Number of Hours
(Estimated)

Proposed Activities

Biostatistics

Was shown multivariable studies
and how it could improve QM in
organ transplantation.

2

Epidemiology

Created new avenues in the route
of epi and how it could apply new
treatment avenues.

3

Social and Behavioral Sciences

Learned all about clinical research 3/hr
and organ transplantation, as well
as, how to apply these new skills.

Environmental Health

N/A

Public Health Administration and
Leadership

N/A

CrossCutting/Interdisciplinary
Values

Proposed Activities

Number of Hours
(Estimated)

Communication and Informatics

Communicated effectively with all 10/hr
colleagues and worked on my
presentation skills.

Diversity and Culture

N/A

Leadership

Worked on creating my own
10/hr
synopsis to present to the director
and board of directors.
Took initiative on my own and
10-15/hr
proposed my own ideas on how
things could be improved.

Professionalism

Cassie Rodriguez
Program Planning

N/A

Public Health Biology

N/A

Systems Thinking

Learned discipline in pursuing
5-10/hr
knowledge in a new field (Quality
management). I also learned how to
search new data base systems.

